All news

Biolog patent

Biolog patent

US company Biolog this week received a patent for its Phenotype
MicroArray technology. The patent, number US 6,472,201, is granted
for comparative phenotypic analysis of two or more microorganisms
using a number of substrates within...

Research pursuits

Research pursuits

Drug discovery company Pharmacopeia and healthcare business
AstraZeneca have extended their research collaboration. The
companies announced this week that they will shift their efforts
from the generation of screening libraries to...

Agreement for 3DP, J&J

Agreement for 3DP, J&J

3-Dimensional Pharmaceuticals (3DP) said this week that the
research term under its thrombin collaboration with two of the
Johnson & Johnson family of companies, Centocor and Johnson
& Johnson Pharmaceutical Research and Development,...

Funding for TransTech

Funding for TransTech

US TransTech Pharma has completed two rounds of investments in the
company, extending over the last nine months, totalling $24.5
million (€22.8m). The investments came from its largest
shareholder, New York-based MacAndrews &...

Agreement in 3DP

Agreement in 3DP

3-Dimensional Pharmaceuticals (3DP) said this week that the
research term under its thrombin collaboration with two of the
Johnson & Johnson family of companies, Centocor and Johnson
& Johnson Pharmaceutical Research and Development,...

Inflammation investigated

Inflammation investigated

US Pharmacopeia has entered into a research collaboration focused
on inflammation with Celgene Corporation. The companies will work
together to identify promising small molecule lead compounds
suitable for further development.

IVAX remains 'active'

IVAX remains 'active'

Pharmaceutical and veterinary product manufacturer IVAX corporation
has acquired ChemSource, a manufacturer of active pharmaceutical
ingredients based in Puerto Rico.

Rhodia losses

Rhodia losses

French specialty chemicals company Rhodia today reported net sales
of €6,617 million in 2002, representing a nine per cent drop
compared with 2001.

Agreeing on liver cells

Agreeing on liver cells

Exten Industries reported today that its wholly owned subsidiary,
MultiCell Technologies, a liver cell engineering and research
organisation in Warwick, US has just signed a nonexclusive license
agreement with a major pharmaceutical...

Patent for HCS

Patent for HCS

High Content Screening company Cellomics announced today that the
Canadian Intellectual Property Office has issued Cellomics'
Canadian Patent No. 2,328,194 entitled 'A System for Cell-Based
Screening.'

GW refutes media comments

GW refutes media comments

In relation to recent media comments relating to its
commercialisation discussions UK company GW Pharmaceuticals said in
a statement this week that it has consistently stated its
commercial strategy 'to be to enter into partnerships...

Valentis wins ruling

Valentis wins ruling

US Valentis announced that its wholly-owned subsidiary, PolyMASC
Pharmaceuticals, has received a favourable ruling from the Japanese
Patent Office in regard to patent invalidation proceedings brought
by ALZA Corporation, a unit of...

Ecopia discovery

Ecopia discovery

Canadian drug development company Ecopia BioSciences on Monday
announced that it had filed patent applications for the first two
novel compounds using its proprietary drug discovery platform -
suggesting investments by the company...

Voridian contract for Eastman

Voridian contract for Eastman

Emerson Process Management has received a multi-year contract from
Voridian, a division of Eastman Chemical, to upgrade automation
systems at Voridian's polyethylene terephthalate (PET) polymers
plants in Columbia and in Cosoleacaque,...

Follow us

Products

View more

Webinars